Table:
begin	end	state
1	31	cytoplasmic
32	53	transmembrane
54	59	non-cytoplasmic
60	84	transmembrane
85	95	cytoplasmic
96	116	transmembrane
117	121	non-cytoplasmic
122	147	transmembrane
148	159	cytoplasmic
160	185	transmembrane
186	194	non-cytoplasmic
195	214	transmembrane
215	249	cytoplasmic
250	271	transmembrane
272	283	non-cytoplasmic
284	306	transmembrane
307	313	cytoplasmic
314	331	transmembrane
332	336	non-cytoplasmic
337	355	transmembrane
356	375	cytoplasmic
376	401	transmembrane
402	407	non-cytoplasmic
408	426	transmembrane
427	438	cytoplasmic

Input:
>WP_052306240.1 NCBI__GCF_000020045.1:WP_052306240.1
MRDSTSGDSSANAAVDPKLLRRAAFASFIGNFVEWFDYASYGYLATIIAVVFFPKTDGSA
GLLAAYGVFAISFIVRPVGGIVWGHFGDKIGRRASLSLSILIMSASTFVIALLPTYAQVG
VLAPVLLLLVRVVQGFSASGEYAGASAFLAEYAPSNRRGFYTSIVPASTAAGLLFGSILI
AIMHAVLSSEQLHSFGWRLPFLLAAPFGLIGRYIRVKLEDTPRFKALEQQSHVARAPIAE
LLGKHRGKMLIAFGVTCLNAVAFYLVLSYMPTYLSTELGMDETASFIAATISLTAYIGLI
FVMGALSDRLGRKSMLIGASILFAVLTVPLFKGLGGAGFMTIVAIQIAFGALLTMNDGTL
PCFLSEIFPTRVRYSGFAFCFNAANALFGGTAPLVATWLIGATGSKLAPAWYLVGAAIVA
LIAMSVSRETSHAPLADE

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server